association

Full identifier: http://purl.org/np/RAEXlhtka0sWqDGxkfaPZ5kozaD96IfOpkMMKI4aH7Os8#association

Assigned to 1 class:

Minted in Nanopublication

 RAEXlhtka0 comment approve/disapprove edit as derived nanopublication create new with same template

This is a local identifier minted within the nanopublication. http://purl.org/np/RAEXlhtka0...#association This association http://www.w3.org/2000/01/rdf-schema#label has label (this is a literal) "adcetris is a cd3 directed antibody drug conjugate indicated for treatment of adult patients with previously untreated stage iii or iv classical hodgkin lymphoma chl in combination with doxorubicin vinblastine and dacarbazine 1 1 classical hodgkin lymphoma chl at high risk of relapse or progression as post autologous hematopoietic stem cell transplantation auto hsct consolidation 1 2 classical hodgkin lymphoma chl after failure of auto hsct or after failure of at least two prior multi agent chemotherapy regimens in patients who are not auto hsct candidates 1 3 previously untreated systemic anaplastic large cell lymphoma salcl or other cd3 expressing peripheral t cell lymphomas ptcl including angioimmunoblastic t cell lymphoma and ptcl not otherwise specified in combination with cyclophosphamide doxorubicin and prednisone 1 4 systemic anaplastic large cell lymphoma salcl after failure of at least one prior multi agent chemotherapy regimen 1 5 primary cutaneous anaplastic large cell lymphoma pcalcl or cd3 expressing mycosis fungoides mf who have received prior systemic therapy 1 6 adcetris is indicated for the treatment of adult patients with previously untreated stage iii or iv chl in combination with doxorubicin vinblastine and dacarbazine adcetris is indicated for the treatment of adult patients with chl at high risk of relapse or progression as post autologous hematopoietic stem cell transplantation auto hsct consolidation adcetris is indicated for the treatment of adult patients with chl after failure of auto hsct or after failure of at least two prior multi agent chemotherapy regimens in patients who are not auto hsct candidates adcetris is indicated for the treatment of adult patients with previously untreated salcl or other cd3 expressing ptcl including angioimmunoblastic t cell lymphoma and ptcl not otherwise specified in combination with cyclophosphamide doxorubicin and prednisone adcetris is indicated for the treatment of adult patients with salcl after failure of at least one prior multi agent chemotherapy regimen adcetris is indicated for the treatment of adult patients with pcalcl or cd3 expressing mf who have received prior systemic therapy" .
This is the identifier for this whole nanopublication. http://purl.org/np/RAEXlhtka0... This nanopublication date and time when the nanopublication was created http://purl.org/dc/terms/created was created on (this is a literal) "2021-07-03T14:58:06.103+02:00" .
This is the identifier for this whole nanopublication. http://purl.org/np/RAEXlhtka0... This nanopublication links to the assertion template that was used to create this nanopublication https://w3id.org/np/o/ntemplate/wasCreatedFromTemplate was created from the assertion template http://purl.org/np/RAManV5GZI... RAManV5GZI .
This is the identifier for this whole nanopublication. http://purl.org/np/RAEXlhtka0... This nanopublication links to the provenance template that was used to create this nanopublication https://w3id.org/np/o/ntemplate/wasCreatedFromProvenanceTemplate was created from the provenance template http://purl.org/np/RANwQa4ICW... RANwQa4ICW .
This is the identifier for this whole nanopublication. http://purl.org/np/RAEXlhtka0... This nanopublication links to the publication info template that was used to create this nanopublication https://w3id.org/np/o/ntemplate/wasCreatedFromPubinfoTemplate was created from the publication info template http://purl.org/np/RAA2MfqdBC... RAA2MfqdBC .
This is a local identifier minted within the nanopublication. http://purl.org/np/RAEXlhtka0...#sig sig http://purl.org/nanopub/x/hasSignatureTarget has as target This is the identifier for this whole nanopublication. http://purl.org/np/RAEXlhtka0... this nanopublication .
This is a local identifier minted within the nanopublication. http://purl.org/np/RAEXlhtka0...#sig sig http://purl.org/nanopub/x/hasAlgorithm has the algorithm (this is a literal) "RSA" .

Leoni Bücken, 3 Jul 2021, 12:58:06 UTC

References

Nanopublication Part Subject Predicate Object Published By Published On
links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion
association
Leoni Bücken
2021-07-03T12:58:06.103Z
links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion
association
adcetris is a cd3 directed antibody drug conjugate indicated for treatment of adult patients with previously untreated stage iii or iv classical hodgkin lymphoma chl in combination with doxorubicin vinblastine and dacarbazine 1 1 classical hodgkin lymphoma chl at high risk of relapse or progression as post autologous hematopoietic stem cell transplantation auto hsct consolidation 1 2 classical hodgkin lymphoma chl after failure of auto hsct or after failure of at least two prior multi agent chemotherapy regimens in patients who are not auto hsct candidates 1 3 previously untreated systemic anaplastic large cell lymphoma salcl or other cd3 expressing peripheral t cell lymphomas ptcl including angioimmunoblastic t cell lymphoma and ptcl not otherwise specified in combination with cyclophosphamide doxorubicin and prednisone 1 4 systemic anaplastic large cell lymphoma salcl after failure of at least one prior multi agent chemotherapy regimen 1 5 primary cutaneous anaplastic large cell lymphoma pcalcl or cd3 expressing mycosis fungoides mf who have received prior systemic therapy 1 6 adcetris is indicated for the treatment of adult patients with previously untreated stage iii or iv chl in combination with doxorubicin vinblastine and dacarbazine adcetris is indicated for the treatment of adult patients with chl at high risk of relapse or progression as post autologous hematopoietic stem cell transplantation auto hsct consolidation adcetris is indicated for the treatment of adult patients with chl after failure of auto hsct or after failure of at least two prior multi agent chemotherapy regimens in patients who are not auto hsct candidates adcetris is indicated for the treatment of adult patients with previously untreated salcl or other cd3 expressing ptcl including angioimmunoblastic t cell lymphoma and ptcl not otherwise specified in combination with cyclophosphamide doxorubicin and prednisone adcetris is indicated for the treatment of adult patients with salcl after failure of at least one prior multi agent chemotherapy regimen adcetris is indicated for the treatment of adult patients with pcalcl or cd3 expressing mf who have received prior systemic therapy
Leoni Bücken
2021-07-03T12:58:06.103Z
links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion
association
Leoni Bücken
2021-07-03T12:58:06.103Z
links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion
association
Leoni Bücken
2021-07-03T12:58:06.103Z
links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion
association
Leoni Bücken
2021-07-03T12:58:06.103Z
links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion
association
Leoni Bücken
2021-07-03T12:58:06.103Z
links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion
association
Leoni Bücken
2021-07-03T12:58:06.103Z
links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion
association
Leoni Bücken
2021-07-03T12:58:06.103Z

Raw

TriG(txt), JSON-LD(txt), N-Quads(txt), XML(txt)